Melanoma Institute Australia Fellowship Program

MIA offers a number of unique clinical and research-based Fellowships each year to train and educate the melanoma clinicians of the future. These Fellowships offer an outstanding opportunity for high-level training in medical oncology, melanoma surgical oncology, melanoma pathology, and dermatology.

Applications are invited from qualified General or Plastic Surgeons for the Melanoma Institute Australia Fellowship in Melanoma and Surgical Oncology

This program is based at the Melanoma Institute Australia’s North Sydney campus, as well as the Mater Hospital Crows Nest, and Royal Prince Alfred Hospital Camperdown.

This position is formatted at a post Fellowship level (FRACS or equivalent) and is suitable for surgeons seeking to develop a vocational interest in the field. 

Each year we offer two clinical and research-based Fellowships, which are for twelve months. The Fellowships involve a substantial clinical workload in dedicated outpatient clinics, operating sessions and weekly multidisciplinary meetings. 

The Melanoma Institute Australia is one of the world’s largest melanoma services, and access to its internationally respected Melanoma Research Database provides the opportunity to undertake significant research during this Fellowship.

Applications are accepted from Australian and non-Australian candidates. 

Interested candidates should submit the following:

  • curriculum vitae
  • cover letter highlighting why you want to become an MIA Melanoma Surgery Fellow
  • proof of specialist qualification
  • current medical registration/licensing
  • medical indemnity
  • contact details of three referees


Apply Now

Each year Melanoma Institute Australia (MIA) offers two full-time Fellowship positions for medical oncology trainees. These Fellowships are for one year in duration. You must either be a Medical Oncology Trainee or recently qualified RACP Fellow in Medical Oncology (or overseas equivalent).

These positions will provide a unique opportunity for the right individuals to obtain training in the treatment and care of melanoma and complex skin cancer patients in a multidisciplinary, clinical and translational research environment, with an emphasis on management of patients on Ph I, II, III clinical trials, treated with novel targeted and immune therapies.

  • Join a world-class organisation in the provision of melanoma care, research and education
  • Be at the forefront of immuno-oncology treatment, clinical trials and research
  • Opportunity to participate in world-leading clinical research
  • A dynamic environment in a recognised centre of excellence

MIA is an independent, non-profit research institute located in North Sydney (NSW, Australia). The Institute is formally affiliated with the University of Sydney and collaborates with clinicians at Royal Prince Alfred Hospital, Royal North Shore Hospital, Westmead Hospital and St Vincent’s and Mater Health to improve the outcome of patients with complex skin cancer. Our team of medical oncologists sees approximately 500 new patients each year and lead a large number of clinical trials of novel agents, including investigator-initiated clinical and translational studies. The Institute has become a major referral centre in Australia, and the care and research conducted by the Institute is widely regarded as world-class.

These positions are based at MIA in North Sydney and will enable the successful applicants to work within a dynamic and high-volume multidisciplinary team focused on the treatment of melanoma, with research links to Westmead Hospital, Royal Prince Alfred and Royal North Shore Hospital. These positions offer an ideal opportunity to the right candidates to work alongside leading medical oncologists, to receive training in the care of melanoma patients, gain expertise in the use of immunotherapy and targeted therapy, gain a detailed understanding in the conduct of clinical trials, as well as gain exposure to world-leading clinical and translational research programs.

These positions will involve participation in outpatient multidisciplinary melanoma care, strong involvement in the conduct and medical oversight of medical oncology clinical trials, and the conduct of clinical research programs. The fellows will be expected to participate in the academic activities of the Institute, including conducting research projects for presentation at major international conferences and publication in high ranking journals. Opportunity for part-time postgraduate study for a Masters through The University of Sydney is available, as is the potential to transfer after completion of the fellowship into a full-time PhD at the University of Sydney or Macquarie University.

Applicants need to hold a FRACP part 1 and 2 exam or equivalent, be eligible for registration with the Medical Board of Australia; and have completed at least 2 core years of advanced training in medical oncology.

Priority is given to Australian candidates.

For UK applicants, you will need to have at least MRCP Part 2 (with PACES preferred) and have equivalent clinical experience at registrar/SHO level in Medical Oncology.  

Appropriate regulatory assistance will be given to facilitate the best overall candidates.

Interested candidates should submit the following:

  • curriculum vitae
  • cover letter highlighting why you want to become an MIA Melanoma Fellow
  • proof of specialist qualification
  • current medical registration/licensing
  • medical indemnity
  • contact details of three referees


Apply Now

There are currently no Fellowships available in this specialty.

Should you wish to express your interest, please send a cover letter and your curriculum vitae to careers@melanoma.org.au

Melanoma Institute Australia (MIA) and Royal Prince Alfred Hospital (RPAH) offer one year Fellowships, involving work at RPAH, MIA Poche Centre and The University of Sydney.

The Fellowship is suitable for qualified pathologists/final year anatomical pathology trainees. The position will provide a unique opportunity for the right individual to:

  • enhance their clinical diagnostic skills in pigmented lesion pathology and dermatopathology,
  • obtain additional experience/training in surgical/molecular pathology and research,
  • gain experience in interpretation of difficult consultation cases (>2500 annually)
  • participate in the MIA translational melanoma research program
  • enhance their knowledge of the treatment and care of melanoma patients.

MIA is a world leader in melanoma research, clinical care and education. It is an independent, non- profit organisation that is formally affiliated with the University of Sydney and the RPAH. The Institute is staffed by an internationally recognised multidisciplinary team of senior clinicians and researchers. The award winning MIA translational research program is supported by research funding from the National Health and Medical Research Council of Australia and Cancer Institute New South Wales. The MIA Biospecimen Bank contains the largest number of annotated melanoma specimens worldwide. The Institute is a leading site for melanoma clinical trials.

Pathology is a critical aspect of the multidisciplinary care of melanoma patients at MIA. All patients who are referred for care at MIA routinely have their pathology reviewed by MIA pathologists (over 1500 new melanoma cases each year). The tissue pathology service for MIA is provided by the Department of Tissue Pathology and Diagnostic Oncology at the RPAH, Sydney where there is a dedicated team of pathologists with special expertise in the diagnosis of pigmented lesions (including Professor Richard Scolyer, Dr Robert Rawson, Dr Peter Ferguson and Dr Andrew Colebatch). In addition, Prof Scolyer receives a large number of consultation cases from other pathologists both nationally and internationally. These unique resources offer unparalleled opportunities to both gain clinical experience in dermatopathology and to perform translation clinical and translational research.

Positions are based in the Department of Tissue Pathology and Diagnostic Oncology at the RPAH and enables the successful applicant to work within a dynamic and high volume department. The department is an academic Pathology Department in a large tertiary referral hospital and is responsible for providing a high quality diagnostic service in all areas of Anatomical Pathology including surgical pathology, molecular pathology, electron microscopy and cytopathology. It services all subspecialities and receives a large number of consultation cases.

Fellows are expected to participate in the academic activities of the Institute. It is envisaged that the Fellows position would involve 50% clinical pathology and 50% research. They would be invited to participate in the routine reporting of the department to gain further clinical experience, if desired, at a level commensurate with their experience/qualifications.

The role would encompass the following core areas:

  • Obtain training and education in the pathological diagnosis and reporting of melanocytic pathology, dermatopathology and other pathology
  • Develop an understanding of pathology reporting standards
  • Participate in the MIA research program on molecular determinants of risk, progression and treatment response in melanoma and other pathology research projects including the melanoma genome project.
  • Participate in the MIA and RPAH training and education activities
  • Present at the weekly melanoma multidisciplinary team meeting
  • Gain further expertise in other areas of diagnostic and molecular pathology at a major tertiary referral centre

Interested fellows should be a Fellow of the Royal College of Pathologists of Australasia, or equivalent, or be in their final year of training. They must also be eligible for registration with the Medical Board of Australia.

Should you wish to express your interest in a fellowship please submit your resume and cover letter to careers@melanoma.org.au